{"article_link": "https://www.frontiersin.org/articles/10.3389/fimmu.2022.938240/full", "data": [{"id": "data_1", "omics": "Transcriptomics", "link": "https://www.ncbi.nlm.nih.gov/bioproject/PRJNA859010", "format": "FASTQ", "source": "Sequence Read Archive (SRA)", "public_id": "PRJNA859010"}, {"id": "data_2", "omics": "Chromatin Accessibility (ATAC-seq)", "link": "https://www.ncbi.nlm.nih.gov/bioproject/PRJNA859010", "format": "FASTQ", "source": "Sequence Read Archive (SRA)", "public_id": "PRJNA859010"}, {"id": "data_3", "omics": "Proteomics", "link": "http://www.proteomexchange.org/cgi/GetDataset?ID=PXD035459", "format": "RAW", "source": "ProteomeXchange", "public_id": "PXD035459"}], "analyses": [{"id": "analysis_1", "analysis_name": "ATAC-seq", "analysis_data": ["data_2"], "label": {"condition": ["unstimulated", "CD40L/IL21-stimulated"]}}, {"id": "analysis_2", "analysis_name": "Bulk RNA-seq", "analysis_data": ["data_1"], "label": {"condition": ["unstimulated", "CD40L/IL21-stimulated"]}}, {"id": "analysis_3", "analysis_name": "Proteomics", "analysis_data": ["data_3"], "label": {"condition": ["CD40L/IL21-stimulated"]}}, {"id": "analysis_4", "analysis_name": "Differential Chromatin Accessibility Analysis", "analysis_data": ["data_2"], "label": {"group": ["TACI mutation carriers", "wild-type"]}}, {"id": "analysis_5", "analysis_name": "Differential Unstimulated RNA-seq", "analysis_data": ["data_1"], "label": {"group": ["TACI mutation carriers", "wild-type"]}}, {"id": "analysis_6", "analysis_name": "Differential Stimulated RNA-seq", "analysis_data": ["data_1"], "label": {"group": ["TACI mutation carriers", "wild-type"]}}, {"id": "analysis_7", "analysis_name": "Differential Proteomics", "analysis_data": ["data_3"], "label": {"group": ["TACI mutation carriers", "wild-type"]}}, {"id": "analysis_8", "analysis_name": "Gene Set Enrichment Analysis (RNA-seq)", "analysis_data": ["analysis_5", "analysis_6"], "label": {"condition": ["unstimulated", "CD40L/IL21-stimulated"]}}, {"id": "analysis_9", "analysis_name": "Gene Set Enrichment Analysis (Proteomics)", "analysis_data": ["analysis_7"], "label": {"condition": ["CD40L/IL21-stimulated"], "group": ["TACI mutation carriers", "wild-type"]}}], "results": [{"analysis_id": "analysis_4", "metrics": "DARs", "value": "1,356 (743 in TACI mutation carriers, 613 in wild-type)", "features": []}, {"analysis_id": "analysis_5", "metrics": "DEGs", "value": "13 (5 upregulated, 8 downregulated)", "features": ["HLA-B", "NR4A2", "THEMIS2", "QPCT", "GADD45B", "CCNB3", "AXIN2", "ZNF235", "DNAJC12", "UBXN10", "MANSC1", "TRIP13", "JPT2"]}, {"analysis_id": "analysis_6", "metrics": "DEGs", "value": "1,558 (720 upregulated, 838 downregulated)", "features": ["complement", "inflammatory response", "allograft rejection", "TNF-a signaling via NF-kB", "hypoxia", "p53 signaling", "UV response", "interferon-a response", "fatty acid metabolism", "protein secretion", "oxidative phosphorylation"]}, {"analysis_id": "analysis_7", "metrics": "Differential Proteins", "value": "3,805", "features": ["coagulation", "interferon-a (IFN-a)", "interferon-g (IFN-g)", "oxidative phosphorylation", "E2F targets", "DNA repair pathways"]}, {"analysis_id": "analysis_8", "metrics": "Enriched Pathways", "value": "12", "features": ["TNF-a signaling via NF-kB", "hypoxia", "p53 signaling", "UV response", "interferon-a response", "fatty acid metabolism", "protein secretion", "oxidative phosphorylation", "complement", "inflammatory response", "allograft rejection", "MYC-V2 target genes"]}, {"analysis_id": "analysis_9", "metrics": "Enriched Pathways", "value": "6", "features": ["coagulation", "interferon-a (IFN-a)", "interferon-g (IFN-g)", "oxidative phosphorylation", "MYC-V2 target genes", "E2F targets"]}]}